| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Glass Mitchell | Director, Chief Medical Off., Director | 1185 AVENUE OF THE AMERICAS,, SUITE 249, NEW YORK | /s/ Mitchell Glass | 2025-11-17 | 0002023649 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | QCLS | Common stock | Award | $0 | +11.4K | +1057.41% | $0.00 | 12.5K | Nov 14, 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Represents a grant of Restricted Stock Units ("RSUs"). The RSUs were granted to the Reporting Person on October 3, 2025, subject to stockholder approval of an amendment to the Issuer's Q/C Technologies, Inc. 2021 Equity Incentive Plan (the "Plan Amendment"), under which the RSUs were granted. The Issuer's stockholders approved the Plan Amendment on November 14, 2025. The RSUs vested immediately upon issuance. |